levodopa has been researched along with metaraminol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kisara, K; Sakurada, S; Shoji, T | 1 |
Costentin, J; Marçais, H; Protais, P; Schwartz, JC | 1 |
Kisara, K; Shoji, T; Tadano, T | 1 |
Cummings, MG; Dodsworth, J; Fischer, JE; James, JH | 1 |
Ekman, K; Hirvonen, J; Huupponen, I; Kankkunen, T; Kontturi, K; Lahtinen, K; Sundell, M | 1 |
5 other study(ies) available for levodopa and metaraminol
Article | Year |
---|---|
[Central effects of beta-phenylethylamines. (8). Increase in spontaneous motor activities of mice caused by intracerebrally administered metaramino].
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Isocarboxazid; Levodopa; Male; Metaraminol; Methyltyrosines; Mice; Motor Activity; Time Factors | 1977 |
[Rapid and prolonged facilitation of stereotyped motor behavior (verticalization) induced by apomorphine in mice previously submitted to stimulation of dopaminergic receptors].
Topics: Animals; Apomorphine; Behavior; Behavior, Animal; Corpus Striatum; Dextroamphetamine; Dopamine; Humans; Hypothermia; Levodopa; Male; Metaraminol; Mice; Sensory Receptor Cells; Stereotyped Behavior; Time Factors | 1976 |
[Central action of beta-phenylethylamine derivatives (10). Effect of L-Dopa on metaraminol induced motor activity (author's transl)].
Topics: Animals; Benserazide; Brain; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Male; Metaraminol; Mice; Motor Activity; Norepinephrine; Serotonin; Time Factors | 1977 |
Diagnosis and therapy of the hepatorenal syndrome: a tentative classification.
Topics: Blood Volume; Cardiac Output; Diuresis; Humans; Kidney Diseases; Levodopa; Liver Circulation; Liver Diseases; Metaraminol; Norepinephrine; Phenylephrine; Tyramine; Vascular Resistance | 1973 |
Improved stability and release control of levodopa and metaraminol using ion-exchange fibers and transdermal iontophoresis.
Topics: Delayed-Action Preparations; Drug Compounding; Drug Stability; Drug Storage; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Ion Exchange Resins; Iontophoresis; Levodopa; Metaraminol; Oxidation-Reduction; Skin Absorption | 2002 |